Detalles de la búsqueda
1.
Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma.
Ann Hematol
; 91(1): 73-82, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21559811
2.
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).
Blood
; 113(18): 4153-62, 2009 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-19141862
3.
Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
Haematologica
; 101(6): e245-8, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26992948
4.
Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations.
Genes (Basel)
; 11(9)2020 08 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32825230
5.
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
Haematologica
; 92(5): 612-8, 2007 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-17488684
6.
Prognostic significance and treatment implications of minimal residual disease studies in Philadelphia-negative adult acute lymphoblastic leukemia.
Mediterr J Hematol Infect Dis
; 6(1): e2014062, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25237475
Resultados
1 -
6
de 6
1
Próxima >
>>